Targeting Molecular Dysregulation in Ulcerative Colitis: A Paired Cellular Perspective on CD4+, CD8+, and IL-6

Roxana Elena Mirica1,2,3, Andrei Coman4, Monica State5

  • 1Department of Social Insurance Medicine, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Insights

Histologic healing in ulcerative colitis (UC) involves changes in T cells and reduced IL-6. This suggests coordinated immune regulation beyond clinical remission, potentially guiding future therapies.

Area of Science:

  • Gastroenterology
  • Immunology
  • Cellular Biology

Background:

  • Histological healing is a key indicator of remission in ulcerative colitis (UC).
  • The roles of mucosal T lymphocytes and cytokines during UC healing are not fully understood.

Purpose of the Study:

  • To investigate the dynamics of T lymphocytes (CD4+, CD8+) and IL-6 during histologic healing in UC patients.
  • To correlate these changes with disease activity and immune homeostasis.

Main Methods:

  • Retrospective analysis of paired colonic biopsies from 20 adult UC patients during active inflammation and healing.
  • Immunohistochemistry for CD3, CD4, CD8, and IL-6.
  • Quantification of lymphocyte densities and semi-quantitative IL-6 scoring.

Main Results:

  • Intraepithelial CD4+ T cells decreased, while intraepithelial CD8+ T cells increased during healing.
  • Lamina propria CD4+ T cells showed variable persistence.
  • IL-6 expression significantly decreased in epithelial and stromal compartments.
  • Enhanced coordination between CD4+ and CD8+ cells was observed during healing.

Conclusions:

  • Histologic healing in UC involves compartment-specific T cell shifts and reduced IL-6.
  • These changes reflect coordinated immune regulation and resolution of inflammation.
  • Cellular and cytokine biomarkers may help monitor healing and guide UC therapies.